Natural killer cell therapy (Ohio State University Comprehensive Cancer Center)

自然杀伤细胞疗法（Ohio State University Comprehensive Cancer Center）

Report date: 2022/12/16 14:36:23

Base Information

Drug NameNatural killer cell therapy (Ohio State University Comprehensive Cancer Center)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Donor > AllogeneicCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > Natural killer cell therapy
Mechanisms of ActionNatural killer cell replacements
TargetsNot applicable
Therapy Area/IndicationsBrain metastasesSkin MelanomaBreast Neoplasms +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesOhio State University Comprehensive Cancer Center
China Registration ClassN/A

Develop Information

Active CompaniesOhio State University Comprehensive Cancer Center
Inactive CompaniesN/A
Active IndicationsBrain metastasesSkin MelanomaBreast Neoplasms +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A